Last update: Aug. 6, 2018
Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T½.
Read the Comment.
Centrally acting muscle relaxant with anticholinergic effects.
At last update no published on excretion in breast milk data were found. Even on humans pharmacokinetic data is barely found.
Its anticholinergic effect has a theoretical risk of inhibiting lactation especially during the early postpartum weeks.
Until more data about this drug regarding breastfeeding is available, safer known alternatives should be of choice, especially in the neonatal period and in case of prematurity.
If administered during breastfeeding, use small doses and monitor drowsiness and adequate feeding of the infants.
(Not to be confused with the trademark Pridinol, which in some countries corresponds to Terfenadine)
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM